Status: Current

Date: December, 2024.

Status:

Date: July, 2024.

Jul 2, 2024 ... Supporting tobacco users to quit is core demand-reduction measure of the WHO Framework Convention on Tobacco Control (WHO FCTC) and a key ...

Pediatric Basic Life Support Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

Status: Current

Date: June, 2024.

This 2019 focused update to the American Heart Association pediatric basic life support guidelines follows the 2019 systematic review of the effects of dispatcher-assisted cardiopulmonary resuscitation (DA-CPR) on survival of infants and children with out-of-hospital cardiac arrest. This systematic review and the primary studies identified were analyzed by the Pediatric Task Force of the International Liaison Committee on Resuscitation. It aligns with the International Liaison Committee on Resuscitation’s continuous evidence review process, with updates published when the International Liaison Committee on Resuscitation completes a literature review based on new published evidence. This update summarizes the available pediatric evidence supporting DA-CPR and provides treatment recommendations for DA-CPR for pediatric out-of-hospital cardiac arrest. Four new pediatric studies were reviewed. A systematic review of this data identified the association of a significant improvement in the rates of bystander CPR and in survival 1 month after cardiac arrest with DA-CPR. The writing group recommends that emergency medical dispatch centers offer DA-CPR for presumed pediatric cardiac arrest, especially when no bystander CPR is in progress. No recommendation could be made for or against DA-CPR instructions when bystander CPR is already in progress.

Status: Current

Date: June, 2024.

Intra-abdominal Infections

Status: Current

Date: June, 2024.

As the first part of an update to the clinical practice guideline on the diagnosis and management of complicated intra-abdominal infections in adults, children, and pregnant people, developed by the Infectious Diseases Society of America, we present 21 updated recommendations. These recommendations span risk assessment, diagnostic imaging, and microbiological evaluation. This is Part 1 of an update to the 2010 SIS/IDSA Guidelines on Diagnosing and Managing Complicated Intra-Abdominal Infections in Adults and Children.

Rabies

Status:

Date: June, 2024.

Jun 5, 2024 ... ... treatment, prevention, WHO response. ... Once clinical symptoms appear, rabies is virtually 100% fatal. The ...

Falls Prevention Interventions

Status: Published

Date: June, 2024.

Counseling guideline for Senior patients. Grade: B, C. Category: Injury Prevention, Musculoskeletal Disorders

Status: Current

Date: March, 2024.

Status: Current

Date: March, 2024.

Pacing as a Treatment for Reflex-Mediated Syncope: A Systematic Review for the Evaluation and Management of Patients With Syncope

Status: Current

Date: March, 2024.

Objective:To determine, using systematic review of the biomedical literature, whether pacing reduces risk of recurrent syncope and relevant clinical outcomes among adult patients with reflex-mediated syncope.Methods:MEDLINE (through PubMed), EMBASE, and the Cochrane Central Register of Controlled Trials (through October 7, 2015) were searched for randomized trials and observational studies examining pacing and syncope, and the bibliographies of known systematic reviews were also examined. Studies were rejected for poor-quality study methods and for the lack of the population, intervention, comparator, or outcome(s) of interest.Results:Of 3,188 citations reviewed, 10 studies met the inclusion criteria for systematic review, including a total of 676 patients. These included 9 randomized trials and 1 observational study. Of the 10 studies, 4 addressed patients with carotid sinus hypersensitivity, and the remaining 6 addressed vasovagal syncope. Among the 6 open-label (unblinded) studies, we found that pacing was associated with a 70% reduction in recurrent syncope (relative risk [RR]: 0.30; 95% confidence interval [CI]: 0.15–0.60). When the 2 analyzable studies with double-blinded methodology were considered separately, there was no clear benefit (RR: 0.73; 95% CI: 0.25–2.1), but confidence intervals were wide. The strongest evidence was from the randomized, double-blinded ISSUE-3 (Third International Study on Syncope of Uncertain Etiology) trial, which demonstrated a benefit of pacing among patients with recurrent syncope and asystole documented by implantable loop recorder.Conclusions:There are limited data with substantive evidence of outcome ascertainment bias, and only 2 studies with a double-blinded study design have been conducted. The evidence does not support the use of pacing for reflex-mediated syncope beyond patients with recurrent vasovagal syncope and asystole documented by implantable loop recorder.

Status: Current

Date: March, 2024.

Guidelines for Adult Basic Life Support and Cardiopulmonary Resuscitation Quality

Status: Current

Date: March, 2024.

Cardiopulmonary resuscitation is a lifesaving technique for victims of sudden cardiac arrest. Despite advances in resuscitation science, basic life support remains a critical factor in determining outcomes. The American Heart Association recommendations for adult basic life support incorporate the most recently published evidence and serve as the basis for education and training for laypeople and healthcare providers who perform cardiopulmonary resuscitation.

Guideline for Management of Ventricular Arrhythmias and Prevention of Sudden Cardiac Death

Status: Current

Date: March, 2024.

Guideline for Management of Ventricular Arrhythmias and Prevention of Sudden Cardiac Death

Status: Current

Date: March, 2024.

Background:Although large randomized clinical trials have found that primary prevention use of an implantable cardioverter-defibrillator (ICD) improves survival in patients with cardiomyopathy and heart failure symptoms, patients who receive ICDs in practice are often older and have more comorbidities than patients who were enrolled in the clinical trials. In addition, there is a debate among clinicians on the usefulness of electrophysiological study for risk stratification of asymptomatic patients with Brugada syndrome.Aim:Our analysis has 2 objectives. First, to evaluate whether ventricular arrhythmias (VAs) induced with programmed electrostimulation in asymptomatic patients with Brugada syndrome identify a higher risk group that may require additional testing or therapies. Second, to evaluate whether implantation of an ICD is associated with a clinical benefit in older patients and patients with comorbidities who would otherwise benefit on the basis of left ventricular ejection fraction and heart failure symptoms.Methods:Traditional statistical approaches were used to address 1) whether programmed ventricular stimulation identifies a higher-risk group in asymptomatic patients with Brugada syndrome and 2) whether ICD implantation for primary prevention is associated with improved outcomes in older patients (>75 years of age) and patients with significant comorbidities who would otherwise meet criteria for ICD implantation on the basis of symptoms or left ventricular functionResults:Evidence from 6 studies of 1138 asymptomatic patients were identified. Brugada syndrome with inducible VA on electrophysiological study was identified in 390 (34.3%) patients. To minimize patient overlap, the primary analysis used 5 of the 6 studies and found an odds ratio of 2.3 (95% CI: 0.63–8.66; p=0.2) for major arrhythmic events (sustained VAs, sudden cardiac death, or appropriate ICD therapy) in asymptomatic patients with Brugada syndrome and inducible VA on electrophysiological study versus those without inducible VA.Ten studies were reviewed that evaluated ICD use in older patients and 4 studies that evaluated unique patient populations were identified. In our analysis, ICD implantation was associated with improved survival (overall hazard ratio: 0.75; 95% confidence interval: 0.67–0.83; p<0.001). Ten studies were identified that evaluated ICD use in patients with various comorbidities including renal disease, chronic obstructive pulmonary disease, atrial fibrillation, heart disease, and others. A random effects model demonstrated that ICD use was associated with reduced all-cause mortality (overall hazard ratio: 0.72; 95% confidence interval: 0.65–0.79; p<0.0001), and a second “minimal overlap” analysis also found that ICD use was associated with reduced all-cause mortality (overall hazard ratio: 0.71; 95% confidence interval: 0.61–0.82; p<0.0001). In 5 studies that included data on renal dysfunction, ICD implantation was associated with reduced all-cause mortality (overall hazard ratio: 0.71; 95% confidence interval: 0.60–0.85; p<0.001).

Guideline for Management of Ventricular Arrhythmias and Prevention of Sudden Cardiac Death

Status: Current

Date: March, 2024.

Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Status: Current

Date: March, 2024.

Drugs That May Cause or Worsen Heart Failure

Guidelines on Dispatcher-Assisted CPR and Cardiac Arrest Centers

Status: Archived

Date: December, 2020.

...American Diabetes Association The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate...

Status: Published

Date: February, 2018.

Screening guideline for Adult, Senior patients. Grade: D. Category: Cancer

Adolescent Idiopathic Scoliosis Screening

Status: Published

Date: January, 2018.

Screening guideline for Adolescent, Pediatric patients. Grade: I. Category: Musculoskeletal Disorders

Status: Archived

Date: October, 1999.

...E M Benjamin; M S Schneider; K T Hinchey OBJECTIVE: A controlled trial with 15-month follow-up was conducted in two outpatient clinics to study the effects of using the problem-based learning technique to implement a diabetes clinical practice guideline. RESEARCH DESIGN AND METHODS: A total of 144...

Immunomodulators

Status: In Development

Date: January, 0001.

Staphylococcus aureus Bacteremia

Status: In Development

Date: January, 0001.

Status

In Progress

Inactive

Current

Published

Endorsed

Archived

In Development

Organ System

Organism

COVID-19

Development and Behavior

Mental Health Conditions and Substance Abuse

Counseling

Screening

Adolescent

Adult

Senior

tuberculosis

Tuberculosis

influenza

Metabolic

nutritional

and Endocrine Conditions

Obstetric and Gynecologic Conditions

Pediatric

Breastfeeding

Coronavirus disease (COVID-19)

Cancer

Infectious Diseases

Practice Guideline

IDSA

Vaccines / Immunization

Treatment

Viruses / Viral Infections

Current

Respiratory

Continuing Medical Education (CME)

Clinical Trials

American Heart Association

Abortion care

depression

dengue

Hepatitis B

Injury Prevention

Miscellaneous

mpox

Genital Herpes Simplex Virus

Journal Articles

Extract

Perinatal Care

meningitis

Review Article

Fungi / Fungal Infections

female genital mutilation

Musculoskeletal Disorders

Clinical Practice Guidelines

diabetes

chronic obstructive pulmonary disease

HIV / AIDS

mental health

Preventive medication

Antimicrobial Resistance

tobacco cessation

Rabies

Cervical cancer

diphtheria

sepsis

Bacteria / Bacterial Infections

chronic low back pain

antimicrobial resistance

Diagnostics / Testing

Abstract

Cardiovascular Disorders (Heart and Vascular Diseases)

abortion care

Hepatitis

Typhoid

Journal Article

antibiotics

newborn care

Research Article

drug dependence

Vision and Hearing Disorders

Sepsis

Family Planning

Tick-borne Illness

Palliative care

Influenza

Chagas disease

Editorial

C. diff

HIVMA

Endocarditis

Meeting Abstract